Financial Snapshot

Revenue
$0.00
TTM
Gross Margin
Net Earnings
-$3.242M
TTM
Current Assets
$458.6K
Q2 2016
Current Liabilities
$467.4K
Q2 2016
Current Ratio
98.13%
Q2 2016
Total Assets
$1.249M
Q2 2016
Total Liabilities
$1.725M
Q2 2016
Book Value
-$476.8K
Q2 2016
Cash
P/E
-0.01727
Aug 15, 2024 EST
Free Cash Flow
-$1.277M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2021 2020 2015 2014 2013 2012 2011 2010 2009 2008 2007

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2021 2020 2015 2014 2013 2012 2011 2010 2009 2008 2007

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2021 2020 2015 2014 2013 2012 2011 2010 2009 2008 2007

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2021 2020 2015 2014 2013 2012 2011 2010 2009 2008 2007

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2021 2020 2015 2014 2013 2012 2011 2010 2009 2008 2007

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2021 2020 2015 2014 2013 2012 2011 2010 2009 2008 2007

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2021 2020 2015 2014 2013 2012 2011 2010 2009 2008 2007

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $55.986 Thousand

About ECGI Holdings, Inc.

ECGI Holdings, Inc. engages in the provision of viticulture and luxury fashion products and services. The company is headquartered in Los Angeles, California and currently employs 1 full-time employees. The company went IPO on 2007-12-03. The firm is focused on California distressed cannabis assets, properties zoned for cannabis cultivation and process, and cannabis companies operating in market sectors with national expansion possibilities. The Company’s subsidiaries include National Cardio Group, Inc. and Mount Fire 29 Corp. Its Mount Fire 29 Corp. subsidiary is focused on cannabis cultivation. The firm owns specialized extraction equipment, which is built to process large volumes of industrial hemp (up to 500 pounds per hour) and distilled crude material through a high-volume liquid to liquid (L2L) process designed to generate optimal refined product.

Industry: Services-Management Consulting Services Peers: ABBOTT LABORATORIES Advanced Biomedical Technologies Inc. THC Therapeutics, Inc. Bionik Laboratories Corp. CYduct Diagnostics, Inc. INVIVO THERAPEUTICS HOLDINGS CORP. Wellness Center USA, Inc.